Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis JOURNAL OF CYSTIC FIBROSIS Banner, K. H., de Jonge, H., Elborn, S., Growcott, E., Gulbins, E., Konstan, M., Moss, R., Poll, C., Randell, S. H., Rossi, A. G., Thomas, L., Waltz, D. 2009; 8 (1): 1-8

Abstract

A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008. Key opinion leaders in the field (Hugo De Jonge, Stuart Elborn, Erich Gulbins, Mike Konstan, Rick Moss, Scott Randell and Adriano Rossi), and NIBR scientists were brought together to collectively address three main aims: (i) to identify anti-inflammatory targets in CF, (ii) to evaluate the pros and cons of targeting specific cell types and (iii) to discuss model systems to profile potential therapeutic agents. The highlights of the workshop are captured in this review.

View details for DOI 10.1016/j.jcf.2008.10.002

View details for Web of Science ID 000262553800001

View details for PubMedID 19022708